Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1379570 | Bioorganic & Medicinal Chemistry Letters | 2005 | 5 Pages |
Abstract
A novel series of N-alkyl-substituted cyclic sulfamides were developed from a screening hit. Chemistries were developed which allowed surveys of N-alkyl groups and amines resulting in the identification of N-trifluoroethyl-substituted cyclic sulfamides with good in vitro and in vivo γ-secretase activity. One compound with subnanomolar activity elicited a reduction in brain Aβ40 after oral dosing in APP-YAC mice.
Graphical abstractA novel series of N-alkyl-substituted cyclic sulfamides were developed from a screening hit.Figure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Tim Sparey, Dirk Beher, Jonathan Best, Mirlinda Biba, José L. Castro, Earl Clarke, Joanne Hannam, Timothy Harrison, Huw Lewis, Andrew Madin, Mark Shearman, Bindi Sohal, Nancy Tsou, Christopher Welch, Jonathan Wrigley,